---
schema_version: "secwatch.filing_event.v1"
accession: "0001688757-26-000038"
form_type: "8-K"
ticker: "ESTA"
cik: "0001688757"
company_name: "ESTABLISHMENT LABS HOLDINGS INC."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:48:46.946251+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Establishment Labs Q1 revenue $59.9M (+44.7% YoY); raises FY guidance; adj. EBITDA positive for 3rd quarter

## Summary
- Revenue of $59.9M, up 44.7% YoY; US Motiva sales $19.6M (vs $6.2M Q1 2025).
- Gross margin 70.7% (up from 67.2% YoY); operating loss narrowed to $6.5M from $16.9M.
- Adjusted EBITDA of $1.2M vs loss of $12.1M YoY; cash balance $68.1M.
- FY 2026 revenue guidance raised to $266.5M-$268.5M; minimally invasive revenue seen >$35M.
- Expects free cash flow positive in H2 2026; reaffirms positive adjusted EBITDA each quarter.

## SEC filing metadata
- accession: 0001688757-26-000038
- form_type: 8-K
- ticker: ESTA
- cik: 0001688757
- company_name: ESTABLISHMENT LABS HOLDINGS INC.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1688757/000168875726000038/0001688757-26-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1688757/000168875726000038/esta-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001688757-26-000038
- JSON: https://secwatch.observer/filing/0001688757-26-000038.json
- Plain text: https://secwatch.observer/filing/0001688757-26-000038.txt

## Source-grounded claims
- claim_id: a6c5293081668dc7a10fe3b62f40910111cb7159
  claim: ESTABLISHMENT LABS HOLDINGS INC. reported the first quarter ended March 31, 2026 results: revenue $59.9 million, net income $13.4 million. Guidance raised.
  evidence_excerpt: breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2026. First Quarter Highlights and Outlook (Unaudited) • Revenue of $59.9 million, up 44.7% from Q1 2025, with guidance raised to $266.5 million to $268.5 million • $19.6 million of Motiva sales in the United States, up 13.3% from Q4 2025 • Minimally invasive
  evidence_url: https://www.sec.gov/Archives/edgar/data/1688757/000168875726000038/0001688757-26-000038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.